Diferencia entre revisiones de «Dobutamine»

(Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template))
(Switch SMW query from broadtable to table format for better layout with TOC)
 
(No se muestra una edición intermedia del mismo usuario)
Línea 77: Línea 77:
  |?Has Route=Route
  |?Has Route=Route
  |?Has Population=Population
  |?Has Population=Population
  |format=broadtable
  |format=table
  |headers=plain
  |headers=plain
  |link=subject
  |mainlabel=-
  |sort=Has Indication
  |sort=Has Indication
  |limit=50
  |limit=50

Revisión actual - 21:55 20 mar 2026

General

  • Type: Vasopressors
    • Technically an inotrope as beta 2 stimulation causes vasodilation
    • Should use in combination with a vasopressor (eg norepinephrine) to avoid hypotension
  • Dosage Forms:
  • Common Trade Names:

Adult Dosing

Dosing

  • 2-20mcg/kg/min
    • 10mcg works for most
  • May use in peripheral IV

Rate of Titration

  • Q2-5 min

Pediatric Dosing

Special Populations

  • Pregnancy Rating: B
  • Lactation:
    • Unknown if Dobutamine passes into breast milk
  • Renal Dosing
    • Adult
      • Not defined
    • Pediatric
      • Not defined
  • Hepatic Dosing
    • Adult
      • Not defined
    • Pediatric
      • Not defined

Contraindications

  • Allergy to class/drug

Adverse Reactions

  • Tachyarrhythmias
  • Myocardial ischemia
  • Hypotension as β2 effect may result in vasodilation
    • Caution if SBP <90

Serious

Common

Pharmacology[1]

  • Half-life:
    • 2 minutes
  • Metabolism:
    • In tissues and hepatically
  • Excretion:
    • Urine as metabolites
  • Mechanism of Action:β1 stimulation with variable BP effects

Primary Receptor

  • β1
  • β2

Relative Effects

  • ↑↑↑SV
  • ↑↑HR → increases oxygen demand of heart → can worsen ischemia
  • ↓SVR (transient, from β2 agonism)

Notes

Indications

  • Cardiogenic shock
    • initial agent in low-output heart failure without requiring BP support
  • Tricyclic overdose
  • septic shock with low cardiac output to improve blood flow


Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Coarctation of the aorta5-10mcg/kg/min IVInotropic support for CHFIVPediatric
Congestive heart failure2-20 mcg/kg/min IV dripInotrope (1st line for hypotensive HF)IV dripAdult
Sepsis (main)2-20 mcg/kg/minInotrope for sepsis-related myocardial dysfunctionIV dripAdult
Vasopressors2-5 mcg/kg/min, max 20 mcg/kg/minInotropeIV dripAdult
Vasopressors2-20mcg/kg/minInotrope for cardiogenic shockIVAdult

See Also

http://www.atsjournals.org/doi/abs/10.1164/rccm.201006-0972CI?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed#readcube-epdf

References

  1. Dobutamine: Drug information. UpToDate. www.uptodate.com. Accessed April 2, 2019.